Tristen T Chun

Journal Article Ann Vasc Surg · December 2025 BACKGROUND: The Hemodialysis Reliable Outflow (HeRO) graft combines an arteriovenous graft with a central venous stent, allowing for hemodialysis access in patients with end-stage renal disease limited by central venous stenosis. The impact of anticoagulat ... Full text Link to item Cite

Asian American Representation in Surgical Training in the United States.

Journal Article J Surg Res · October 2, 2025 INTRODUCTION: Asians are considered an over-represented minority in medicine, making up 7% of the US national population but 17.1% of active physicians. However, representation trends are different across surgical specialties, and many surgical residency p ... Full text Link to item Cite

Perioperative and long-term outcomes after Hemodialysis Reliable Outflow (HeRO) graft surgery.

Journal Article J Vasc Surg · October 2025 OBJECTIVE: The Hemodialysis Reliable Outflow (HeRO) graft offers hemodialysis access options for patients who have developed central venous stenosis or occlusion. In this single-center study, we report our perioperative and long-term outcomes after HeRO gr ... Full text Link to item Cite

View All Publications

Recent Grants

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients with End-Stage Renal Disease

Clinical TrialPrincipal Investigator · Awarded by W. L. Gore & Associates, Inc. · 2024 - 2032

A Phase 3 Randomized Study to Compare the Efficacy and Safety of the Humacyte Human Acellular Vessel (HAV) with that of an Autogenous Arteriovenous Fistula (AVF) in Female Patients with End-Stage Renal Disease Requiring He- CLN-Pro-V012 - Pro00114567

Clinical TrialPrincipal Investigator · Awarded by Humacyte Global, Inc. · 2024 - 2032

View All Grants

Education, Training & Certifications

Boston University, School of Medicine · 2012 M.D.

Boston University · 2008 M.A.

Johns Hopkins University · 2005 M.S.

Johns Hopkins University · 2004 B.S.